Results 101 to 110 of about 39,994 (209)

Exploring the Antimicrobial Efficacy of Mesenchymal Stem Cell Secretome Against Klebsiella pneumoniae in Urinary Tract Infections

open access: yesClinical and Translational Science, Volume 19, Issue 6, June 2026.
ABSTRACT Antimicrobial resistance (AMR) has become a global health crisis, with Klebsiella pneumoniae (K. pneumoniae) emerging as a major driver of AMR and a leading cause of urinary tract infections (UTIs). Mesenchymal stem cell (MSC)‐derived secretomes have gained attention for their antimicrobial properties.
Leen Ali   +3 more
wiley   +1 more source

Medication errors associated with carbapenems

open access: yesКачественная клиническая практика, 2018
Purpose. The purpose of this study was to discover the prevalence and types of medication errors associated with the use of carbapenems. Materials and methods.
A. V. Kuz’mina   +3 more
doaj  

Poster Sessions

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Carbapenem-resistant and carbapenem use in Japan: an ecological study

open access: yesJournal of International Medical Research, 2019
Objective This study focused on carbapenem resistance in Pseudomonas aeruginosa and examined potential ecological correlations with carbapenem use in Japan. Methods The proportion of carbapenem-resistant P. aeruginosa isolates from 2015 and 2016 by prefecture was obtained from the Japan Nosocomial Infections Surveillance system.
Fumitaka Terahara, Hiroshi Nishiura
openaire   +1 more source

Publication Only

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Mechanisms of resistance to the carbapenems [PDF]

open access: yesJournal of Antimicrobial Chemotherapy, 1995
D, Livingstone, M J, Gill, R, Wise
openaire   +2 more sources

Co-Occurrence of Resistance to Aminoglycosides and Carbapenems in <i>Klebsiella pneumoniae</i>: A Critical Threat to Public Health. [PDF]

open access: yesInt J Microbiol
de Queiroz Cavalcanti de Sa RA   +11 more
europepmc   +1 more source

Clinical outcomes of carbapenem therapy in OXA-48-producing Enterobacterales infections: a French multicentre cohort, systematic review, and meta-analysis. [PDF]

open access: yesEmerg Microbes Infect
Dortet L   +8 more
europepmc   +1 more source

The synergistic action of reduced membrane permeability and antibiotic sequestration as a novel mechanism for carbapenem resistance in <i>Campylobacter</i>. [PDF]

open access: yesmBio
Chen X   +15 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy